MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$287,415K
Prepaid expenses and
other current assets
$22,202K
Accounts receivable
$3,567K
Current income tax
receivable
$2,250K
Total current assets
$315,434K
Operating lease
right-of-use assets
$16,841K
Property and equipment,
net
$4,297K
Restricted cash
$1,449K
Total assets
$338,021K
Total liabilities and
stockholders equity
$338,021K
Total stockholders
equity
$303,132K
Total liabilities
$34,889K
Accumulated deficit
-$481,765K
Treasury stock, at cost
21,126,760 and no shares as...
$384,558K
Additional paid-in capital
$1,169,451K
Total current
liabilities
$20,414K
Operating lease
liabilities, net of current...
$14,475K
Common stock, par value
of 0.0001 per share...
$4K
Accrued expenses and
other current...
$16,039K
Current portion of
operating lease...
$2,408K
Accounts payable
$1,967K
Back
Back
Balance Sheet
source: myfinsight.com
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)